These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 15077309)

  • 1. Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies.
    Sonesson SE; Salomonsson S; Jacobsson LA; Bremme K; Wahren-Herlenius M
    Arthritis Rheum; 2004 Apr; 50(4):1253-61. PubMed ID: 15077309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome and growth of infants fetally exposed to heart block-associated maternal anti-Ro52/SSA autoantibodies.
    Skog A; Wahren-Herlenius M; Sundström B; Bremme K; Sonesson SE
    Pediatrics; 2008 Apr; 121(4):e803-9. PubMed ID: 18381509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Ro52/SSA antibody-exposed fetuses with prolonged atrioventricular time intervals show signs of decreased cardiac performance.
    Bergman G; Eliasson H; Bremme K; Wahren-Herlenius M; Sonesson SE
    Ultrasound Obstet Gynecol; 2009 Nov; 34(5):543-9. PubMed ID: 19795521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.
    Mevorach D; Elchalal U; Rein AJ
    Curr Opin Rheumatol; 2009 Sep; 21(5):478-82. PubMed ID: 19584727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing fetal cardiac conduction in anti-Ro/SSA-positive pregnancies.
    Sonesson SE; Hedlund M; Ambrosi A; Wahren-Herlenius M
    Rheumatology (Oxford); 2017 Oct; 56(10):1755-1762. PubMed ID: 28957562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants.
    Jaeggi E; Laskin C; Hamilton R; Kingdom J; Silverman E
    J Am Coll Cardiol; 2010 Jun; 55(24):2778-84. PubMed ID: 20538173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies: a prospective, observational, fetal kinetocardiogram-based study.
    Rein AJ; Mevorach D; Perles Z; Gavri S; Nadjari M; Nir A; Elchalal U
    Circulation; 2009 Apr; 119(14):1867-72. PubMed ID: 19332471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
    Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
    Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low titer, isolated anti Ro/SSA 60 kd antibodies is correlated with positive pregnancy outcomes in women at risk of congenital heart block.
    Tonello M; Hoxha A; Mattia E; Zambon A; Visentin S; Cerutti A; Ghirardello A; Milanesi O; Ruffatti A
    Clin Rheumatol; 2017 May; 36(5):1155-1160. PubMed ID: 28204891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study.
    Friedman DM; Kim MY; Copel JA; Davis C; Phoon CK; Glickstein JS; Buyon JP;
    Circulation; 2008 Jan; 117(4):485-93. PubMed ID: 18195175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of heart block in children of SSA/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth pattern.
    Ambrosi A; Salomonsson S; Eliasson H; Zeffer E; Skog A; Dzikaite V; Bergman G; Fernlund E; Tingström J; Theander E; Rydberg A; Skogh T; Öhman A; Lundström U; Mellander M; Winqvist O; Fored M; Ekbom A; Alfredsson L; Källberg H; Olsson T; Gadler F; Jonzon A; Kockum I; Sonesson SE; Wahren-Herlenius M
    Ann Rheum Dis; 2012 Mar; 71(3):334-40. PubMed ID: 21953338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound findings in fetal congenital heart block associated with maternal anti-Ro/SSA and Anti-La/SSB antibodies.
    Lai J; Clark TJ; Tan JH; Delaney S; Jolley JA
    Ultrasound Q; 2015 Mar; 31(1):34-6. PubMed ID: 25706362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal ECG: a novel predictor of atrioventricular block in anti-Ro positive pregnancies.
    Gardiner HM; Belmar C; Pasquini L; Seale A; Thomas M; Dennes W; Taylor MJ; Kulinskaya E; Wimalasundera R
    Heart; 2007 Nov; 93(11):1454-60. PubMed ID: 17085531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Home Monitoring for Fetal Heart Rhythm During Anti-Ro Pregnancies.
    Cuneo BF; Sonesson SE; Levasseur S; Moon-Grady AJ; Krishnan A; Donofrio MT; Raboisson MJ; Hornberger LK; Van Eerden P; Sinkovskaya E; Abuhamad A; Arya B; Szwast A; Gardiner H; Jacobs K; Freire G; Howley L; Lam A; Kaizer AM; Benson DW; Jaeggi E
    J Am Coll Cardiol; 2018 Oct; 72(16):1940-1951. PubMed ID: 30309472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conduction system disease in fetuses evaluated for irregular cardiac rhythm.
    Cuneo BF; Strasburger JF; Wakai RT; Ovadia M
    Fetal Diagn Ther; 2006; 21(3):307-13. PubMed ID: 16601344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases--a multicentre prospective study.
    Gerosa M; Cimaz R; Stramba-Badiale M; Goulene K; Meregalli E; Trespidi L; Acaia B; Cattaneo R; Tincani A; Motta M; Doria A; Zulian F; Milanesi O; Brucato A; Riboldi P; Meroni PL
    Rheumatology (Oxford); 2007 Aug; 46(8):1285-9. PubMed ID: 17449486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective echocardiographic evaluation of atrioventricular conduction in fetuses with maternal Sjögren's antibodies.
    Van Bergen AH; Cuneo BF; Davis N
    Am J Obstet Gynecol; 2004 Sep; 191(3):1014-8. PubMed ID: 15467582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal echocardiographic screening of pregnancies of mothers with anti-Ro and/or anti-La antibodies.
    Gladman G; Silverman ED; Yuk-Law ; Luy L; Boutin C; Laskin C; Smallhorn JF
    Am J Perinatol; 2002 Feb; 19(2):73-80. PubMed ID: 11938480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal Doppler echocardiographic diagnosis and successful steroid therapy of Luciani-Wenckebach phenomenon and endocardial fibroelastosis related to maternal anti-Ro and anti-La antibodies.
    Raboisson MJ; Fouron JC; Sonesson SE; Nyman M; Proulx F; Gamache S
    J Am Soc Echocardiogr; 2005 Apr; 18(4):375-80. PubMed ID: 15846168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perinatal outcome of fetus with isolated congenital second degree atrioventricular block without maternal anti-SSA/Ro-SSB/La antibodies.
    Chang YL; Hsieh PC; Chang SD; Chao AS; Liang CC; Soong YK
    Eur J Obstet Gynecol Reprod Biol; 2005 Oct; 122(2):167-71. PubMed ID: 16219517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.